Successful maternal-foetal outcome using nitric oxide and sildenafil in pulmonary hypertension with atrial septal defect and HIV infection

Singapore Medical Journal

Volumn 53, Issue 1, 2012, Pages

  Ng, W P K ^a   Yip, W L J ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Atrial septal defect; HIV infection; Pregnancy; Pulmonary hypertension; Sildenafil

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DEXAMETHASONE; ENOXAPARIN; GENTAMICIN; LAMIVUDINE; NELFINAVIR; NITRIC OXIDE; OXYTOCIN; PENICILLIN G; SILDENAFIL; WARFARIN; ZIDOVUDINE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE REPORT; CESAREAN SECTION; DISEASE ASSOCIATION; DYSPNEA; ELECTROCARDIOGRAPHY; FEMALE; FETUS LUNG MATURATION; HEART ATRIUM SEPTUM DEFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENORRHAGIA; OXYGEN SATURATION; PREGNANCY OUTCOME; PULMONARY HYPERTENSION; SINGLE DRUG DOSE; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANTI-HIV AGENTS; ANTICOAGULANTS; ENOXAPARIN; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HIV INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; NITRIC OXIDE; PIPERAZINES; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PURINES; SULFONES; VASODILATOR AGENTS; ZIDOVUDINE;

EID: 84855860382     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 1998; 31:1650-7.
2. Mangano DT. Anaesthesia for the pregnant cardiac patient. In: Shnider SM, Levinson G, eds. Anaesthesia for Obstetrics, 3rd edn. Baltimore: Williams & Wilkins, 1983:502-8.
3. Fuster V, Steele PM, Edwards WD, et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984; 70:580-7.
4. Roberts NV, Keast PJ. Pulmonary hypertension and pregnancy-a lethal combination. Anaesth Intensive Care 1990; 18:366-74.
5. Robinson DE, Leicht CH. Epidural analgesia with low-dose bupivacaine and fentanyl for labor and delivery in a parturient with severe pulmonary hypertension. Anaesthesiology 1988; 68:285-8.
6. Robinson JN, Banerjee R, Landzberg MJ, Thiet MP. Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension. Am J Obstet Gynecol 1999; 180:1045-6.
7. Rabe KF, Tenor H, Dent G, et al. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Am J Physiol 1994; 266:L536-43.
8. Galiè N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005; 353:2148-57.
9. Nunes H, Humbert M, Sitbon O, et al. Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2003; 167:1433-9.
10. Sitbon O, Gressin V, Speich R, et al. Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2004; 170:1212-7.
11. Battenfeld R, Schuh W, Schobel C. Studies on reproductive toxicity of iloprost in rats, rabbits and monkeys. Toxicol Lett 1995; 78:223-34.
12. Monnery L, Nanson J, Charlton G. Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. Br J Anaesth 2001; 87:295-8.
13. Stewart R, Tuazon D, Olson G, Duarte AG. Pregnancy and Primary pulmonary hypertension: successful outcome with epoprostenol therapy. Chest 2001; 119:973-5.
14. Bendayan D, Hod M, Oron G, et al. Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy. Obstet Gynecol 2005; 106:1206-10.
15. Molelekwa V, Akhter P, McKenna P, Bowen M, Walsh K. Eisenmenger's syndrome in a 27 week pregnancy-management with bosentan and sildenafil. Ir Med J 2005; 98:87-8.
16. Lacassie HJ, Germain AM, Valdés G, et al. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol 2004; 103:1118-20.
17. Lepore JJ, Maroo A, Pereira NL, et al. Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. Am J Cardiol 2002; 90:677-80.